skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 542,225  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: resource type: Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990

Full text available

2
Correction: Evolution and consequences of individual responses during the COVID-19 outbreak
Material Type:
Article
Add to My Research

Correction: Evolution and consequences of individual responses during the COVID-19 outbreak

PloS one, 2023-10, Vol.18 (10), p.e0292775-e0292775 [Peer Reviewed Journal]

COPYRIGHT 2023 Public Library of Science ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Abbas et al 2023 Abbas et al ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0292775

Full text available

3
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Material Type:
Article
Add to My Research

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432

Digital Resources/Online E-Resources

4
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

5
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Material Type:
Article
Add to My Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923

Full text available

6
Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated
Material Type:
Article
Add to My Research

Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated

PloS one, 2022-07, Vol.17 (7), p.e0271154-e0271154 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The PLOS ONE Staff 2022 The PLOS ONE Staff ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0271154 ;PMID: 35789344

Full text available

7
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Material Type:
Article
Add to My Research

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

Nature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702

Full text available

8
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Nature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689

Full text available

9
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Material Type:
Article
Add to My Research

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

The Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480

Full text available

10
Correction for Howard et al., An evidence review of face masks against COVID-19
Material Type:
Article
Add to My Research

Correction for Howard et al., An evidence review of face masks against COVID-19

Proceedings of the National Academy of Sciences - PNAS, 2024-04, Vol.121 (18), p.e2314762120-e2314762120 [Peer Reviewed Journal]

Copyright National Academy of Sciences Apr 30, 2024 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2314762120 ;PMID: 38662552

Full text available

11
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

The Lancet (British edition), 2022-01, Vol.399 (10321), p.237-248 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02753-7 ;PMID: 34953526

Full text available

12
Imaging tests for the diagnosis of COVID‐19
Material Type:
Article
Add to My Research

Imaging tests for the diagnosis of COVID‐19

Cochrane database of systematic reviews, 2020-06, Vol.2020 (6) [Peer Reviewed Journal]

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD013639

Full text available

13
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Material Type:
Article
Add to My Research

A pooled testing strategy for identifying SARS-CoV-2 at low prevalence

Nature (London), 2021-01, Vol.589 (7841), p.276-280 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 14, 2021 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2885-5 ;PMID: 33086375

Full text available

14
Myocarditis With COVID-19 mRNA Vaccines
Material Type:
Article
Add to My Research

Myocarditis With COVID-19 mRNA Vaccines

Circulation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]

2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357

Full text available

15
A glass half‐full: positive impacts of the COVID‐19 pandemic on the delivery of public hospital urology care
Material Type:
Article
Add to My Research

A glass half‐full: positive impacts of the COVID‐19 pandemic on the delivery of public hospital urology care

BJU international, 2022-06, Vol.130 (S1), p.37-38 [Peer Reviewed Journal]

2022 The Authors BJU International © 2022 BJU International Published by John Wiley & Sons Ltd. ;BJUI © 2022 BJU International ;ISSN: 1464-4096 ;EISSN: 1464-410X ;DOI: 10.1111/bju.15722 ;PMID: 35224826

Full text available

16
Synchronous, Group Virtual Delivery of a Childhood Weight Program: Participation and Effectiveness
Material Type:
Article
Add to My Research

Synchronous, Group Virtual Delivery of a Childhood Weight Program: Participation and Effectiveness

Obesity (Silver Spring, Md.), 2021-12, Vol.29, p.168-169 [Peer Reviewed Journal]

Copyright Blackwell Publishing Ltd. Dec 2021 ;ISSN: 1930-7381 ;EISSN: 1930-739X

Full text available

17
Ivermectin for preventing and treating COVID‐19
Material Type:
Article
Add to My Research

Ivermectin for preventing and treating COVID‐19

Cochrane database of systematic reviews, 2021-04, Vol.2021 (4) [Peer Reviewed Journal]

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD015017

Full text available

18
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Material Type:
Article
Add to My Research

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225

Digital Resources/Online E-Resources

19
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study
Material Type:
Article
Add to My Research

Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study

Journal of medical Internet research, 2020-12, Vol.22 (12), p.e24286-e24286 [Peer Reviewed Journal]

Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. ;Copyright Gunther Eysenbach MD MPH, Associate Professor Dec 2020 ;Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. 2020 ;ISSN: 1438-8871 ;ISSN: 1439-4456 ;EISSN: 1438-8871 ;DOI: 10.2196/24286 ;PMID: 33216726

Full text available

20
Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae
Material Type:
Article
Add to My Research

Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e487-e490 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciac722 ;PMID: 36052466

Full text available

Results 1 - 20 of 542,225  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (372,978)

Refine My Results

Creation Date 

From To
  1. Before 1975  (14)
  2. 1975 To 2003  (6)
  3. 2004 To 2012  (5)
  4. 2013 To 2018  (39)
  5. After 2018  (541,953)
  6. More options open sub menu

Language 

  1. English  (528,092)
  2. Japanese  (16,468)
  3. Spanish  (9,879)
  4. Portuguese  (9,423)
  5. German  (3,077)
  6. French  (2,362)
  7. Russian  (1,946)
  8. Indonesian  (1,319)
  9. Turkish  (1,256)
  10. Chinese  (1,094)
  11. Persian  (777)
  12. Norwegian  (740)
  13. Korean  (490)
  14. Polish  (413)
  15. Arabic  (350)
  16. Italian  (342)
  17. Catalan  (297)
  18. Croatian  (278)
  19. Afrikaans  (275)
  20. Hungarian  (230)
  21. More options open sub menu

Searching Remote Databases, Please Wait